Terns Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
25 Feb 2025	Form 3: Gengos Andrew, Chief Financial Officer No securities owned
24 Feb 2025	Form 3: Azelby Robert, Director No securities owned
11 Feb 2025	Form 3: Strauss David Eric, Principal Accounting Officer Holds 89,673 shares of Common Stock
19 Nov 2024	Form 3: Turner Heather D, Director No securities owned
02 May 2024	Form 3: Jung Melita Sun, Chief Business Officer No securities owned
19 Mar 2024	Form 3: Kuriakose Emil, Chief Medical Officer Holds 58,750 shares of Common Stock
15 Feb 2024	Form 3: Burroughs Amy L., Director No securities owned
28 Jul 2022	Form 3: Tripuraneni Radhika, Director No securities owned
10 Jun 2022	Form 3: Russell Kerry Strong, Chief Medical Officer No securities owned
12 Oct 2021	Form 3: Taylor Ann Elizabeth, Director No securities owned
04 Feb 2021	Form 3: Flynn James E, 10% owner and 3 others
04 Feb 2021	Form 3: Sundaram Senthil Vel, Director
04 Feb 2021	Form 3: Quirk Erin, See Remarks
04 Feb 2021	Form 3: Vignola Mark J., Chief Financial Officer
04 Feb 2021	Form 3: Yoon Seokho Bryan, See Remarks
04 Feb 2021	Form 3: Zhong Weidong, Director Holds 285,714 shares of Common Stock
04 Feb 2021	Form 3: Quigley Jill M., Director
04 Feb 2021	Form 3: Lu Hongbo, Director No securities owned
04 Feb 2021	Form 3: Kindler Jeffrey B, Director
04 Feb 2021	Form 3: Fellows David A, Director

Comments